AMLODIPINE\INDAPAMIDE: 42 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
42
Total FAERS Reports
0
Deaths Reported
25
Hospitalizations
42
As Primary/Secondary Suspect
7
Life-Threatening
First Report: 20170131 · Latest Report: 20250303
What Are the Most Common AMLODIPINE\INDAPAMIDE Side Effects?
#1 Most Reported
Hypokalaemia
19 reports (45.2%)
#2 Most Reported
Confusional state
8 reports (19.0%)
#3 Most Reported
Hyponatraemia
7 reports (16.7%)
All AMLODIPINE\INDAPAMIDE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hypokalaemia | 19 | 45.2% | 0 | 18 |
| Confusional state | 8 | 19.1% | 0 | 2 |
| Acute kidney injury | 7 | 16.7% | 0 | 1 |
| Atrial fibrillation | 7 | 16.7% | 0 | 5 |
| Condition aggravated | 7 | 16.7% | 0 | 6 |
| Hyponatraemia | 7 | 16.7% | 0 | 7 |
| Blood creatine phosphokinase increased | 6 | 14.3% | 0 | 0 |
| Hypocalcaemia | 6 | 14.3% | 0 | 6 |
| Hypochloraemia | 6 | 14.3% | 0 | 6 |
| Prerenal failure | 6 | 14.3% | 0 | 0 |
| Urinary retention | 6 | 14.3% | 0 | 0 |
| Affective disorder | 5 | 11.9% | 0 | 0 |
| Alopecia | 5 | 11.9% | 0 | 0 |
| Back pain | 5 | 11.9% | 0 | 0 |
| Faecaloma | 5 | 11.9% | 0 | 5 |
| Organic erectile dysfunction | 5 | 11.9% | 0 | 0 |
| Potentiating drug interaction | 5 | 11.9% | 0 | 5 |
Who Reports AMLODIPINE\INDAPAMIDE Side Effects? Age & Gender Data
Gender: 44.7% female, 55.3% male. Average age: 67.3 years. Most reports from: FR. View detailed demographics →
Is AMLODIPINE\INDAPAMIDE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 1 | 0 | 1 |
| 2019 | 6 | 0 | 5 |
| 2020 | 14 | 0 | 7 |
| 2021 | 1 | 0 | 1 |
| 2024 | 6 | 0 | 6 |
| 2025 | 7 | 0 | 2 |
What Is AMLODIPINE\INDAPAMIDE Used For?
| Indication | Reports |
|---|---|
| Hypertension | 28 |
| Product used for unknown indication | 9 |
Official FDA Label for AMLODIPINE\INDAPAMIDE
Official prescribing information from the FDA-approved drug label.